Page last updated: 2024-10-28

haloperidol and Cryptococcosis

haloperidol has been researched along with Cryptococcosis in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Cryptococcosis: Fungal infection caused by genus CRYPTOCOCCUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ji, C1
Liu, N1
Tu, J1
Li, Z1
Han, G1
Li, J1
Sheng, C1

Other Studies

1 other study available for haloperidol and Cryptococcosis

ArticleYear
Drug Repurposing of Haloperidol: Discovery of New Benzocyclane Derivatives as Potent Antifungal Agents against Cryptococcosis and Candidiasis.
    ACS infectious diseases, 2020, 05-08, Volume: 6, Issue:5

    Topics: Antifungal Agents; Candidiasis; Cryptococcosis; Drug Repositioning; Drug Resistance, Fungal; Haloper

2020